Coherus Oncology Files 2025 Annual Report
Ticker: CHRS · Form: ARS · Filed: Apr 20, 2026 · CIK: 0001512762
| Field | Detail |
|---|---|
| Company | Coherus Oncology, Inc. (CHRS) |
| Form Type | ARS |
| Filed Date | Apr 20, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, coherus-oncology
Related Tickers: CHRS
TL;DR
CHRS filed 2025 ARS. Check financials.
AI Summary
Coherus Oncology, Inc. filed its Annual Report to Security Holders (ARS) on April 20, 2026, for the period ending December 31, 2025. The report details the company's performance and financial standing for the fiscal year 2025. The filing was made with the SEC under accession number 0001104659-26-045272.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Coherus Oncology's operations and financial health for the past fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual report filing, not indicating any immediate new risks or significant changes.
Key Numbers
- 932829 — ARS PDF Size (Size of the main Annual Report to Security Holders document in bytes.)
- 1286462 — Text File Size (Size of the complete submission text file in bytes.)
Key Players & Entities
- Coherus Oncology, Inc. (company) — Filer of the ARS report
- DENNIS M. LANFEAR (person) — Contact person for mailing and business address
- 2026-04-20 (date) — Filing date and acceptance date of the ARS report
- 2025-12-31 (date) — Period of report for the ARS filing
FAQ
What is the accession number for this filing?
The accession number for this filing is 0001104659-26-045272.
When was the Annual Report to Security Holders filed?
The ARS was filed and accepted on April 20, 2026.
What period does this report cover?
This report covers the period ending December 31, 2025.
Who is listed as the contact for Coherus Oncology's mailing and business address?
DENNIS M. LANFEAR is listed as the contact person for both the mailing and business addresses.
What is the SIC code for Coherus Oncology, Inc.?
The SIC code for Coherus Oncology, Inc. is 2836, which pertains to Biological Products (No Diagnostic Substances).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 20, 2026 by DENNIS M. LANFEAR regarding Coherus Oncology, Inc. (CHRS).